Abstract | OBJECTIVE: DESIGN: An inception cohort with a minimum of 18 months of follow-up. SETTING: A tertiary care center and university teaching hospital. PATIENTS: INTERVENTION: MAIN OUTCOME MEASURES: RESULTS: The 1-, 2-, and 3-year actuarial estimate for symptomatic recurrent gustatory sweating was 27%, 63%, and 92%, respectively. In the 7 patients without symptomatic recurrent gustatory sweating, the Minor starch- iodine test revealed persistent gustatory sweating in 6, resulting in an overall 97% rate (32 of 33 patients) for recurrent gustatory sweating. No statistical relationship could be demonstrated between the duration of effectiveness, the incidence of recurrent gustatory sweating, the severity of recurrent gustatory sweating, and the following variables: age, sex, cause of gustatory sweating, skin surface involved, and dose of botulinum toxin type A injection. Within the group of 26 patients with symptomatic recurrent gustatory sweating, (1) the severity of the recurrent gustatory sweating was always reduced when compared with the severity of the initial gustatory sweating, and (2) the recurrent gustatory sweating always remained amenable to reinjection of botulinum toxin type A. CONCLUSIONS:
|
Authors | O Laccourreye, E Akl, R Gutierrez-Fonseca, D Garcia, D Brasnu, B Bonan |
Journal | Archives of otolaryngology--head & neck surgery
(Arch Otolaryngol Head Neck Surg)
Vol. 125
Issue 3
Pg. 283-6
(Mar 1999)
ISSN: 0886-4470 [Print] United States |
PMID | 10190799
(Publication Type: Journal Article)
|
Chemical References |
- Neuromuscular Agents
- Botulinum Toxins, Type A
|
Topics |
- Adolescent
- Adult
- Aged
- Botulinum Toxins, Type A
(administration & dosage, therapeutic use)
- Female
- Humans
- Injections
- Male
- Middle Aged
- Neuromuscular Agents
(administration & dosage, therapeutic use)
- Recurrence
- Retrospective Studies
- Sweating, Gustatory
(therapy)
- Treatment Outcome
|